< Editorial: Oncology biomarkers on the agenda, when visiting Israel
27.02.2017 15:19 Age: 23 days

EuropaBio recommends strengthening the policy environment for insuring the social and economic benefits of biotech SMEs in Europe

On 28 February, 2017, 400 participants, key industrial players, global trend shapers and high-level policy makers will inspire debate on the future of European industry in Brussels.

 The 2017 European Industry Day Event will open with a video message from Commission President Jean-Claude Juncker. Commission Vice-President Jyrki Katainen, and Commissioners El?bieta Bie?kowska and Carlos Moedas will participate. Representatives of traditional and new sectors, entrepreneurs, innovators, start-ups and the tech community will share the stage with key EU political leaders.

EuropaBio – the European Association for Bioindustries - calls to action to EU policymakers with key recommendations for strengthening the policy environment. Policies which are crucial to maintaining a strong potential for successful biotech SMEs include increasing and simplifying access to funding schemes, ensuring access to international markets, aiding mobility of personnel, and developing incentives and legislation tailored to the needs of biotech SMEs. Maintaining Europe’s competitiveness and leadership in this key enabling technology must be a priority in the EU’s industrial agenda to 2020.

A viable biotech SME sector is key to ensuring the future of many of the growth industries and the products and processes they offer citizens in Denmark and Europe. EuropaBio recommends leaders must prioritize public policies, which ensure a thriving SME community in Europe through:


  • Expanding, speeding up, and simplifying access to European and national funding instruments for SMEs
  • Coordinating between funding mechanisms at the European level and at the national level
  • Developing and supporting incentives that respond to the specific needs of SMEs (e.g. EMA SME office)
  • Ensuring that legislation is adapted to the realities and needs of SMEs, and is predictable and workable
  • Enabling access to appropriate expertise in crucial phases of SMEs’ development
  • Facilitating access for SMEs to international markets and mobility of personnel


Read the EuropaBio press release here

Read about the 2017 European Industry Day

University of Copenhagen
Universitetsparken 2
DK-2100 Copenhagen

Mail info@biopeople.ku.dk
Web www.biopeople.dk